Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
Open Access
- 16 August 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 342
Abstract
Background: The efficacy of corticosteroids and intravenous immunoglobulin (IVIG) in pediatric myocarditis remains controversial. Objectives: The authors performed a meta-analysis to assess the therapeutic efficacy of corticosteroids and IVIG in children with myocarditis. Methods: We retrieved the trials on corticosteroids and IVIG therapy, respectively, in pediatric myocarditis from nine databases up to December 2018. Statistical analysis was performed using Review Manager 5.3. Results: Our analysis included 8 studies and 334 pediatric patients. The data demonstrated that children receiving corticosteroids showed no significant improvement on left ventricular ejection fraction (LVEF) from 1 to 8 month-follow-up (MD = 5.17%, 95% CI = -0.26% to 10.60%, P = 0.06), and no significant improvement in death or heart transplantation incidence at the end of follow-up (OR = 1.33, 95% CI = 0.27-6.70, P = 0.73). However, children receiving IVIG revealed a statistically remarkable increase in LVEF at a follow-up over the course of 6 months to 1 year (MD = 18.91%, 95% CI = 11.74-26.08%, P < 0.00001), and a decrease in death or heart transplantation at the end of follow-up (OR = 0.31, 95% CI = 0.12-0.75, P = 0.01). Further comparisons showed that the mortality and heart transplantation rate of children with myocarditis treated with IVIG were significantly lower than those with corticosteroid therapy (t' = 11.336, P < 0.001). Conclusions: IVIG might be beneficial to improve LVEF and survival for myocarditis in children. However, the present evidence does not support corticosteroids as superior to conventional therapy in children with myocarditis. Further randomized controlled trials with a larger sample size are required.Keywords
This publication has 30 references indexed in Scilit:
- 47th Annual Meeting of the Association for European Paediatric Cardiology,AEPC with joint sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery and Asia–Pacific Pediatric Cardiac SocietyCardiology in the Young, 2013
- Recent clinical and translational research on pediatric myocarditisProgress in Pediatric Cardiology, 2011
- Acute viral myocarditis: role of immunosuppression: a prospective randomised studyCardiology in the Young, 2010
- Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC studyEuropean Heart Journal, 2009
- Anti-Inflammatory Actions of Intravenous ImmunoglobulinAnnual Review of Immunology, 2008
- Section 16: Myocarditis: Current TreatmentJournal of Cardiac Failure, 2006
- Outcome of acute fulminant myocarditis in childrenHeart, 2006
- Immunosuppressive Treatment for Inflammatory Cardiomyopathy: Meta-Analysis of Randomized Controlled TrialsInternational Heart Journal, 2005
- Outcomes for children with acute myocarditisCardiology in the Young, 2004
- The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a reviewHeart, 2001